JAK2 and B-cell chronic lymphocytic leukemia: Overall, our data demonstrate that in B-CLL, JAK2 is a key upstream regulator of BTK activation and, more interestingly that BTK is regulated by PTx-dependent and PTx-independent, but JAK2-dependent, distinct signaling pathways triggered by CXCR4.